Donor bone marrow infusions in conjunction with liver-islet allotransplantation in patients with Type 2 diabetes

Transplantation Proceedings

Volumn 29, Issue 1-2, 1997, Pages 745-

  Alejandro, R ^a   Ricordi, C ^b   Angelico, M C ^b   Nery, J ^b   Webb, M ^b   Fernandez, L ^b   Lehman, R ^b   Karatzas, T ^b   Olson, L ^b   Tzakis, A G ^b  

^a DIABETES RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; STEROID; TACROLIMUS;

ALLOGRAFT; BONE MARROW CELL; CLINICAL ARTICLE; CONFERENCE PAPER; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INSULIN RESISTANCE; INSULIN TREATMENT; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

BONE MARROW TRANSPLANTATION; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMOGLOBIN A, GLYCOSYLATED; HISTOCOMPATIBILITY TESTING; HUMANS; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; LIVER CIRRHOSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 12644291969     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(96)00448-4     Document Type: Conference Paper

References (1)

1. Trail KC, Stratta RJ, Larsen JL, et al: Surgery 114:650, 1993